An Aussie social media influencer was rushed to hospital after she endured a severe allergic reaction to getting her lip ...

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin ...

South Africans are questioning the new Choice Assorted biscuit packaging after a TikTok video highlighted plastic-wrapped ...

A woman claims an eyebrow tint left her looking like an ' alien' after she had an allergic reaction that caused her face to ...

Grandmother decided to learn the game to get rid of the stress of her grandson's cancer treatment. However, she later made it ...

Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.

Preliminary BRIUMVI U.S. fourth quarter and full year 2025 net product revenue of approximately $182 million and $594 million, respectively Full Year 2026 target total global revenue of approximately ...

The FDA approved copper histidinate (Zycubo) as the first treatment for Menkes disease in pediatric patients, the agency ...

ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD ...

A significantly higher proportion of 4- to 7-year-olds with peanut allergy using the Viaskin Peanut patch were deemed ...

Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...